Literature DB >> 25362041

Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project.

Silvia Morbelli1, Andrea Brugnolo2, Irene Bossert1, Ambra Buschiazzo1, Giovanni B Frisoni3, Samantha Galluzzi4, Bart N M van Berckel5, Rik Ossenkoppele5, Robert Perneczky6, Alexander Drzezga7, Mira Didic8, Eric Guedj9, Gianmario Sambuceti1, Gianluca Bottoni1, Dario Arnaldi2, Agnese Picco2, Fabrizio De Carli10, Marco Pagani11, Flavio Nobili2.   

Abstract

We aimed to investigate the accuracy of FDG-PET to detect the Alzheimer's disease (AD) brain glucose hypometabolic pattern in 142 patients with amnestic mild cognitive impairment (aMCI) and 109 healthy controls. aMCI patients were followed for at least two years or until conversion to dementia. Images were evaluated by means of visual read by either moderately-skilled or expert readers, and by means of a summary metric of AD-like hypometabolism (PALZ score). Seventy-seven patients converted to AD-dementia after 28.6 ± 19.3 months of follow-up. Expert reading was the most accurate tool to detect these MCI converters from healthy controls (sensitivity 89.6%, specificity 89.0%, accuracy 89.2%) while two moderately-skilled readers were less (p < 0.05) specific (sensitivity 85.7%, specificity 79.8%, accuracy 82.3%) and PALZ score was less (p < 0.001) sensitive (sensitivity 62.3%, specificity 91.7%, accuracy 79.6%). Among the remaining 67 aMCI patients, 50 were confirmed as aMCI after an average of 42.3 months, 12 developed other dementia, and 3 reverted to normalcy. In 30/50 persistent MCI patients, the expert recognized the AD hypometabolic pattern. In 13/50 aMCI, both the expert and PALZ score were negative while in 7/50, only the PALZ score was positive due to sparse hypometabolic clusters mainly in frontal lobes. Visual FDG-PET reads by an expert is the most accurate method but an automated, validated system may be particularly helpful to moderately-skilled readers because of high specificity, and should be mandatory when even a moderately-skilled reader is unavailable.

Entities:  

Keywords:  Alzheimer's disease; FDG-PET; PALZ score; amnestic mild cognitive impairment; visual read

Mesh:

Substances:

Year:  2015        PMID: 25362041     DOI: 10.3233/JAD-142229

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  21 in total

Review 1.  Clinical utility of FDG-PET for the clinical diagnosis in MCI.

Authors:  Javier Arbizu; Cristina Festari; Daniele Altomare; Zuzana Walker; Femke Bouwman; Jasmine Rivolta; Stefania Orini; Henryk Barthel; Federica Agosta; Alexander Drzezga; Peter Nestor; Marina Boccardi; Giovanni Battista Frisoni; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-27       Impact factor: 9.236

Review 2.  A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.

Authors:  Silvia Morbelli; Valentina Garibotto; Elsmarieke Van De Giessen; Javier Arbizu; Gaël Chételat; Alexander Drezgza; Swen Hesse; Adriaan A Lammertsma; Ian Law; Sabina Pappata'; Pierre Payoux; Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09       Impact factor: 9.236

3.  The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis.

Authors:  Silvia Morbelli; Javier Arbizu; Jan Booij; Ming-Kai Chen; Gael Chetelat; Donna J Cross; Mehdi Djekidel; Alexander Drzezga; Ozgul Ekmekcioglu; Valentina Garibotto; Swen Hesse; Kazunari Ishii; Lida Jafari; Adriaan A Lammertsma; Ian Law; Dana Mathews; Satoshi Minoshima; Karina Mosci; Marco Pagani; Sabina Pappata; Daniel Hillel Silverman; Alberto Signore; Elsmarieke Van De Giessen; Victor Villemagne; Henryk Barthel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-06       Impact factor: 9.236

4.  Validation of 18F-FDG-PET Single-Subject Optimized SPM Procedure with Different PET Scanners.

Authors:  Luca Presotto; Tommaso Ballarini; Silvia Paola Caminiti; Valentino Bettinardi; Luigi Gianolli; Daniela Perani
Journal:  Neuroinformatics       Date:  2017-04

Review 5.  Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders.

Authors:  Flavio Nobili; Cristina Festari; Daniele Altomare; Federica Agosta; Stefania Orini; Koen Van Laere; Javier Arbizu; Femke Bouwman; Alexander Drzezga; Peter Nestor; Zuzana Walker; Marina Boccardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-02       Impact factor: 9.236

6.  18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.

Authors:  Silvia Morbelli; Matteo Bauckneht; Dario Arnaldi; Agnese Picco; Matteo Pardini; Andrea Brugnolo; Ambra Buschiazzo; Marco Pagani; Nicola Girtler; Alberto Nieri; Andrea Chincarini; Fabrizio De Carli; Gianmario Sambuceti; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-07       Impact factor: 9.236

7.  Diagnostic performance of an automated analysis software for the diagnosis of Alzheimer's dementia with 18F FDG PET.

Authors:  Sasan Partovi; Roger Yuh; Sara Pirozzi; Ziang Lu; Spencer Couturier; Ulrich Grosse; Mark D Schluchter; Aaron Nelson; Robert Jones; James K O'Donnell; Peter Faulhaber
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-01-15

8.  Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.

Authors:  Lars Frings; Sabine Hellwig; Tobias Bormann; Timo S Spehl; Ralph Buchert; Philipp T Meyer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-15       Impact factor: 9.236

9.  Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer's Disease in Mild Cognitive Impairment.

Authors:  Jae Myeong Kang; Jun-Young Lee; Yu Kyeong Kim; Bo Kyung Sohn; Min Soo Byun; Ji Eun Choi; Soo Kyung Son; Hyung-Jun Im; Jae-Hoon Lee; Young Hoon Ryu; Dong Young Lee
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

10.  Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.

Authors:  Fabrizio De Carli; Flavio Nobili; Marco Pagani; Matteo Bauckneht; Federico Massa; Matteo Grazzini; Cathrine Jonsson; Enrico Peira; Silvia Morbelli; Dario Arnaldi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-31       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.